News
-
-
-
PRESS RELEASE
Zalando delivers strong 2025 results, expects further acceleration in 2026 through scaling AI innovations and announces a share buy-back of up to 300 million euros
Zalando reports strong 2025 results with revenue up 16.8% to 12.3 billion euros and adjusted EBIT climbing 15.6%. Strategy execution through AI innovations drives profitability and share buy-back plan announced -
-
-
-
-
-
PRESS RELEASE
BioVersys Announces First Patient Dosed in Phase 2b Clinical Trial of AlpE in Pulmonary Tuberculosis
BioVersys announces the first patient dosed in a Phase 2b clinical trial of AlpE for pulmonary tuberculosis, collaborating with GSK under UNITE4TB project. Results expected by end of 2027 -
